SG Americas Securities LLC lifted its position in shares of Target Corporation (NYSE:TGT – Free Report) by 333.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 307,065 shares of the retailer’s stock after buying an additional 236,217 shares during the period. SG Americas Securities LLC owned approximately 0.07% of Target worth $27,544,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also recently added to or reduced their stakes in the business. WFA of San Diego LLC purchased a new stake in Target in the second quarter valued at $25,000. Kozak & Associates Inc. increased its position in shares of Target by 2,530.0% during the 2nd quarter. Kozak & Associates Inc. now owns 263 shares of the retailer’s stock worth $27,000 after purchasing an additional 253 shares during the last quarter. Raleigh Capital Management Inc. increased its position in shares of Target by 63.4% during the 2nd quarter. Raleigh Capital Management Inc. now owns 263 shares of the retailer’s stock worth $26,000 after purchasing an additional 102 shares during the last quarter. Investment Research & Advisory Group Inc. purchased a new stake in Target in the 2nd quarter valued at about $29,000. Finally, Heartwood Wealth Advisors LLC acquired a new position in Target in the third quarter valued at about $27,000. 79.73% of the stock is currently owned by institutional investors and hedge funds.
Target Price Performance
Shares of NYSE TGT opened at $103.65 on Thursday. The company has a debt-to-equity ratio of 0.99, a current ratio of 0.97 and a quick ratio of 0.27. The company has a market cap of $46.94 billion, a price-to-earnings ratio of 12.58, a price-to-earnings-growth ratio of 11.35 and a beta of 1.12. The stock’s 50-day moving average is $93.53 and its two-hundred day moving average is $95.69. Target Corporation has a 1-year low of $83.44 and a 1-year high of $145.08.
Analysts Set New Price Targets
TGT has been the topic of a number of research analyst reports. Argus reduced their price target on shares of Target from $135.00 to $125.00 and set a “buy” rating on the stock in a research note on Monday, December 1st. DA Davidson reissued a “buy” rating and issued a $108.00 target price on shares of Target in a research report on Thursday, November 20th. Bank of America lowered their price target on Target from $93.00 to $80.00 and set an “underperform” rating for the company in a research report on Thursday, November 20th. Zacks Research upgraded Target from a “strong sell” rating to a “hold” rating in a report on Wednesday, December 3rd. Finally, BMO Capital Markets lowered their target price on Target from $95.00 to $90.00 and set a “market perform” rating for the company in a report on Thursday, November 20th. Ten research analysts have rated the stock with a Buy rating, twenty-two have issued a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $102.66.
View Our Latest Analysis on Target
Target Company Profile
Target Corporation (NYSE: TGT) is a U.S.-based general merchandise retailer headquartered in Minneapolis, Minnesota. The company operates a network of full-line and small-format stores across the United States alongside a national e-commerce platform and mobile app. Target’s retail assortment spans apparel, home goods, electronics, groceries and household essentials, plus beauty, baby and pet categories. The firm complements national brands with a portfolio of owned and exclusive labels and partnerships that help differentiate its merchandise assortment.
Target traces its roots to the Dayton Company, founded by George Dayton in 1902; the Target discount chain was launched in 1962 and the parent company later adopted the Target Corporation name.
Further Reading
- Five stocks we like better than Target
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
- A month before the crash
- YDES Could Be 2026’s Biotech Breakthrough
- ALERT: Drop these 5 stocks before January 2026!
Receive News & Ratings for Target Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Target and related companies with MarketBeat.com's FREE daily email newsletter.
